How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...

A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

CRISPR allows scientists to more easily edit the pig genome ... Keeping a lid on rejection with human-to-human transplants often requires the lifelong use of immunosuppressant drugs, which have ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.

Signals from the plant cell wall help to orchestrate growth, reproduction and immune function. Can harnessing this molecular ...

Raipur: Medical experts at AIIMS Raipur have called for a comprehensive national effort to boost organ donation in India, ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.

Locus Biosciences announced a research collaboration with Viatris to develop engineered bacteriophage therapies for ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.